From obesity to renal disease, chronic conditions remain some of the toughest challenges in veterinary medicine. Changemakers examine how next-generation therapeutics, supported by diagnostics and other modalities, can deliver sustainable results and change the way veterinarians manage long-term disease.
Gudrun Ravetz
Group Chief Medical Officer
IVC Evidensia
Currently Gudrun works as a Veterinary Consultant to Pet Health Plans from Denplan and as an external interviewer for prospective veterinary students at University of Liverpool. Alongside practicing as a small animal veterinary surgeon on graduating in 2002, Gudrun furthered her interest in the business side of the veterinary profession by studying for the post graduate certificate in business. Gudrun became President at the BVA Member’s Day and AGM on 22 September 2016.
Edwina Gildea MVB MRCVS
Senior Director-Head of Global Medical Portfolio Support-Global Medical Affairs
Zoetis
From generics to emerging technologies and distribution partnerships, innovative routes to market are expanding reach and reshaping the competitive landscape. Leaders share how new models are lowering barriers to entry, driving scale, accelerating time to market, and creating sustainable value across the ecosystem.
Panellists
Steve Shell
President
MWI Animal Health
Peggy Pleines
Global Growth Strategist & M&A Advisor in Animal Health and Pet Care
Founder & Strategic Advisor to Animal Health Brands and Investors